Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Watson

Showing results (181-190 of 234) with videos related to

Pageof 24
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 8, 2020
Age-related retinal thickness in Down's syndrome: A high-risk population for dementiaMadeleine J Walpert, Eduardo M Normando, Tiina Annus, et al.
Cancer Research|May 3, 2006
Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequenceLesley A Anderson, Brian T Johnston, R G Peter Watson, et al.
The Biochemical Journal|June 5, 2008
The secretion inhibitor Exo2 perturbs trafficking of Shiga toxin between endosomes and the trans-Golgi networkRobert A Spooner, Peter Watson, Daniel C Smith, et al.
Bipolar Disorders|December 21, 2016
An investigation of mental imagery in bipolar disorder: Exploring "the mind's eye"Martina Di Simplicio, Fritz Renner, Simon E Blackwell, et al.
British Journal of Haematology|July 24, 2015
Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II studyPeter M Voorhees, Robert Z Orlowski, Flora Mulkey, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancerRebecca S Heist, Xiaofei Wang, Lydia Hodgson, et al.
Genome Research|October 20, 2011
Fusobacterium nucleatum infection is prevalent in human colorectal carcinomaMauro Castellarin, René L Warren, J Douglas Freeman, et al.
Journal of Child & Adolescent Trauma|May 26, 2023
Predicting the Social-Emotional Competence Based on Childhood Trauma, Internalized Shame, Disability/Shame Scheme, Cognitive Flexibility, Distress Tolerance and Alexithymia in an Iranian Sample Using Bayesian RegressionHojjatollah Farahani, Parviz Azadfallah, Peter Watson, et al.
BMC Medicine|November 17, 2023
Mood, Activity Participation, and Leisure Engagement Satisfaction (MAPLES): results from a randomised controlled pilot feasibility trial for low mood in acquired brain injuryAndrea Kusec, Fionnuala C Murphy, Polly V Peers, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 20, 2019
Targeted delivery and endosomal cellular uptake of DARPin-siRNA bioconjugates: Influence of linker stability on gene silencingCornelia Lorenzer, Sonja Streußnig, Emilia Tot, et al.
Pageof 24

Showing results (181-190 of 234) with videos related to

Sort By:
Pageof 24
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 8, 2020
Age-related retinal thickness in Down's syndrome: A high-risk population for dementiaMadeleine J Walpert, Eduardo M Normando, Tiina Annus, et al.
Cancer Research|May 3, 2006
Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequenceLesley A Anderson, Brian T Johnston, R G Peter Watson, et al.
The Biochemical Journal|June 5, 2008
The secretion inhibitor Exo2 perturbs trafficking of Shiga toxin between endosomes and the trans-Golgi networkRobert A Spooner, Peter Watson, Daniel C Smith, et al.
Bipolar Disorders|December 21, 2016
An investigation of mental imagery in bipolar disorder: Exploring "the mind's eye"Martina Di Simplicio, Fritz Renner, Simon E Blackwell, et al.
British Journal of Haematology|July 24, 2015
Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II studyPeter M Voorhees, Robert Z Orlowski, Flora Mulkey, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancerRebecca S Heist, Xiaofei Wang, Lydia Hodgson, et al.
Genome Research|October 20, 2011
Fusobacterium nucleatum infection is prevalent in human colorectal carcinomaMauro Castellarin, René L Warren, J Douglas Freeman, et al.
Journal of Child & Adolescent Trauma|May 26, 2023
Predicting the Social-Emotional Competence Based on Childhood Trauma, Internalized Shame, Disability/Shame Scheme, Cognitive Flexibility, Distress Tolerance and Alexithymia in an Iranian Sample Using Bayesian RegressionHojjatollah Farahani, Parviz Azadfallah, Peter Watson, et al.
BMC Medicine|November 17, 2023
Mood, Activity Participation, and Leisure Engagement Satisfaction (MAPLES): results from a randomised controlled pilot feasibility trial for low mood in acquired brain injuryAndrea Kusec, Fionnuala C Murphy, Polly V Peers, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 20, 2019
Targeted delivery and endosomal cellular uptake of DARPin-siRNA bioconjugates: Influence of linker stability on gene silencingCornelia Lorenzer, Sonja Streußnig, Emilia Tot, et al.
Pageof 24